Metal-organic frameworks have moved from a laboratory curiosity to a commercial materials platform, and their patent landscape is being staked out just as the field reaches scale. A MOF is a porous crystalline material built by linking metal nodes with organic linkers into an ordered framework, producing extraordinarily high surface areas and pores that can be tuned for a target molecule; more than 20,000 distinct MOFs had already been reported by the early 2010s, and the reticular chemistry behind them has continued to mature.¹,² Recognition by the 2025 Nobel Prize in Chemistry, awarded to Susumu Kitagawa, Richard Robson, and Omar Yaghi for the development of metal-organic frameworks, underscored the field's arrival and named applications from carbon-dioxide capture and toxic-gas storage to water harvesting, catalysis, and the separation of per- and polyfluoroalkyl substances from water.³ The intellectual property now divides across three broad regions: the specific framework compositions and structures themselves; the synthesis, shaping, and manufacturing processes that turn a powder into a usable, scalable product; and the application-level systems that integrate a MOF into a working device. Because MOFs serve many functions, freedom-to-operate and white space analysis must span all of them.

The commercial tipping point is reshaping the patent picture. After years in which scale-up and cost were the barriers, industrial-scale production of MOFs for carbon capture has begun, and a wave of startups is pursuing modular capture systems that are easier to scale than incumbent solvent processes, alongside chemical majors moving into manufacturing. Direct air capture of carbon dioxide has been demonstrated in purpose-designed frameworks from the laboratory through pilot scale, distinct from higher-concentration point-source capture.⁶ The scale of activity is large: across the Cypris corpus of more than 500 million patents and scientific papers, the MOF and reticular-chemistry space holds well over 100,000 de-duplicated families and has sustained high-volume filing since around 2018, with the assignee base led by academic institutions and chemical majors such as Sinopec, BASF, and ExxonMobil also prominent, while China accounts for the large majority of families, ahead of the United States, Japan, Germany, and South Korea. This shift moves value from the bare framework composition, where foundational academic estates are concentrated, toward the synthesis, shaping, and system-integration layers. Because applications publish about eighteen months after filing, the most recent synthesis and application filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The landscape divides by application, and the white space sits where a MOF must survive real conditions at low cost. Water stability, cycling durability, and inexpensive, scalable synthesis are the recurring bottlenecks; the criteria for a high-performance water-adsorbing framework, pore size and shape, hydrophilicity, and stability, are well defined but hard to meet at once.⁴ Carbon capture, both point-source and direct air capture, is the most active application and the one drawing the most new entrants; gas separation, increasingly through mixed-matrix membranes,⁷ and gas adsorption and storage⁸ are established; atmospheric water harvesting has advanced from concept toward passive devices,⁵ and newer uses such as direct lithium extraction and contaminant removal are earlier and less crowded. Underlying all of them is the reticular-design principle that lets chemists build frameworks to order for a target function.⁹ Reading the landscape by composition, synthesis route, and application is what separates a crowded region from an open one.

Where the MOF white space is

Water-stable, low-cost frameworks. MOFs that keep performance under humidity and real operating conditions, made by inexpensive routes, are the central bottleneck and a high-value, still-open target.⁴

Scalable synthesis and shaping. Converting powders into pellets, monoliths, and coatings by manufacturable processes is where deployment is decided and where hard-to-design-around process IP concentrates.

Direct air capture sorbents. MOFs tuned for capturing dilute atmospheric carbon dioxide are an active, high-value frontier distinct from point-source capture.⁶

Non-carbon separations. Direct lithium extraction, contaminant and per- and polyfluoroalkyl-substance removal, and other selective separations are earlier and less crowded application layers.

System integration. Contactors, modules, and regeneration systems that turn a MOF into a working unit are a distinct engineering layer separate from the framework chemistry.

How AI-powered landscape and white space analysis helps

Resolving a materials platform that spans many framework chemistries, synthesis routes, and application areas requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by composition, synthesis route, and application across varied terminology, attribution that normalizes academic and commercial filers to canonical entities and tracks new entrants, and continuous monitoring that keeps pace with a field reaching commercial scale. Because MOF advances appear in scientific literature before they are patented, reading both patents and literature gives the earliest signal of where deployable materials are emerging.

Where Cypris fits

Cypris runs patent landscape and white space analysis for materials platforms such as metal-organic frameworks across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by framework composition, by synthesis and shaping route, and by application, carbon capture, gas separation and storage, water harvesting, catalysis, and mineral recovery, and normalizes filers to canonical entities, so a team can resolve which compositions, routes, and applications are crowded and which remain open as white space, and can track new entrants as the field scales. Semantic search across patents and scientific literature connects filings to the underlying materials chemistry research, which is where MOF advances appear first. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined application over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is the metal-organic framework patent landscape? The metal-organic framework patent landscape is the set of patents covering MOFs, porous crystalline materials built from metal nodes and organic linkers, and their uses. It divides across framework compositions, synthesis and shaping processes, and application-level systems. Each application, from carbon capture to gas storage, is a distinct region of the landscape.

Why are MOFs a patenting hotspot now? MOFs are a patenting hotspot now because the field has reached a commercial tipping point, with industrial-scale production beginning for carbon capture and a wave of startups pursuing modular systems. Recognition by the 2025 Nobel Prize in Chemistry has further raised the field's profile. That shift is concentrating new filings in synthesis and application layers.

What application areas does the MOF landscape cover? The MOF landscape covers carbon capture from flue gas and directly from air, gas separation and storage, water harvesting, catalysis, sensing, drug delivery, and recovery of critical minerals such as lithium. Each demands different framework and system properties. Freedom-to-operate and white space analysis must span all of them.

Where is the white space in MOFs? The white space sits where a MOF must survive real conditions cheaply: water-stable, low-cost frameworks and scalable synthesis and shaping are the central bottlenecks, and direct air capture sorbents, non-carbon separations, and system integration are less crowded. The bare framework composition is where foundational estates concentrate. The higher-value opportunities are in deployability.

How is MOF value shifting from composition to manufacturing? MOF value is shifting because, as the field scales, the barrier moves from discovering a framework to making it durable and affordable at volume. Foundational composition estates are concentrated among a few academic groups, while synthesis, shaping, and system-integration IP is where deployment is now decided. That is where much of the defensible, hard-to-design-around value sits.

Why does MOF analysis need scientific literature? MOF analysis needs scientific literature because new frameworks, synthesis routes, and application concepts appear in materials research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the MOF patent landscape? Software for the MOF landscape should cluster activity by framework composition, synthesis route, and application, resolve academic and commercial filers to canonical owners, search patents and scientific literature semantically, and monitor a scaling field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use MOF patent landscape analysis? MOF patent landscape analysis is used by R&D, innovation, IP, and strategy teams at chemicals, materials, carbon-capture, and energy companies, as well as investors and research institutions. It informs where to invest, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across chemicals, advanced materials, energy, and other regulated industries.

Endnotes

1. O'Keeffe, M., Cordova, K. E., Furukawa, H., & Yaghi, O. M. (2013). The chemistry and applications of metal-organic frameworks. Science, 341(6149). https://doi.org/10.1126/science.1230444
2. Li, H., Rampal, N., & Yaghi, O. M. (2025). Reticular chemistry: past, present, and future. Molecular Frontiers Journal. https://doi.org/10.1142/s2529732525300034
3. Royal Swedish Academy of Sciences (2025, October 8). The Nobel Prize in Chemistry 2025 [press release]. https://www.nobelprize.org/prizes/chemistry/2025/press-release/
4. Furukawa, H., Queen, W. L., Yaghi, O. M., et al. (2014). Water adsorption in porous metal-organic frameworks and related materials. Journal of the American Chemical Society, 136(11). https://doi.org/10.1021/ja500330a
5. Diercks, C. S., Kalmutzki, M. J., & Yaghi, O. M. (2018). Metal-organic frameworks for water harvesting from air. Advanced Materials, 30(37). https://doi.org/10.1002/adma.201704304
6. Yao, M.-S., et al. (2023). Direct air capture of CO2 in designed metal-organic frameworks at lab and pilot scale. Carbon Capture Science & Technology, 8. https://doi.org/10.1016/j.ccst.2023.100145
7. Chai, M., Hou, J., & Chen, R. (2023). Metal-organic framework-based mixed matrix membranes for gas separation: recent advances and opportunities. Carbon Capture Science & Technology, 8. https://doi.org/10.1016/j.ccst.2023.100130
8. Sculley, J., Yu, J., Zhou, H.-C., et al. (2011). Carbon dioxide capture-related gas adsorption and separation in metal-organic frameworks. Coordination Chemistry Reviews, 255(15-16). https://doi.org/10.1016/j.ccr.2011.02.012
9. Chen, Z., Kirlikovali, K. O., Li, P., & Farha, O. K. (2022). Reticular chemistry for highly porous metal-organic frameworks: the chemistry and applications. Accounts of Chemical Research, 55(4). https://doi.org/10.1021/acs.accounts.1c00707

‍

Lipid nanoparticles are the delivery system that made mRNA medicines practical, and their patent landscape is distinctive because the delivery layer, rather than the therapeutic payload, is frequently the binding freedom-to-operate constraint. An LNP is built from four carefully selected lipid components, an ionizable lipid that carries the nucleic acid and enables its release inside the cell, a helper phospholipid, cholesterol, and a PEG-lipid that stabilizes the particle, combined in specific molar ratios and manufactured by a defined process.¹ The ionizable lipid is the primary determinant of potency, protonating in the acidic endosome to release the cargo, which is why it is the most heavily engineered and contested element,² and the lipid molar ratio is a first-order formulation variable that developers optimize through statistical design-of-experiments screens.³ Each of these elements can be claimed independently, and the ionizable lipid and the molar-ratio composition are the most heavily contested, so freedom-to-operate for an mRNA vaccine, an RNA therapeutic, or a gene-editing product delivered by LNP is a layered analysis across many owners rather than a single clearance of the drug substance.

The landscape is dense, multi-owner, and among the most litigated in biotechnology. The foundational LNP work traces to a small set of academic and company lineages, and rights have been licensed to many developers, so a single product can implicate several estates at once. The stakes are large: in March 2026, Genevant Sciences and Arbutus Biopharma reached a global settlement with Moderna resolving their lipid-nanoparticle patent dispute for up to $2.25 billion, comprising a $950 million upfront payment and a further $1.3 billion contingent on a pending appellate ruling over a government-use defense.⁴,⁵,⁶ Multiple parallel lipid-nanoparticle suits remain pending across US, European, and Canadian forums, and outcomes have turned on the specific patents asserted rather than on any single view of the technology. The concentration of rights is visible in the patent record: across the Cypris corpus of more than 500 million patents and scientific papers, the LNP and ionizable-lipid space holds on the order of 29,400 de-duplicated families, with filings inflecting sharply during the COVID-19 period, roughly tripling between 2020 and 2023, and the most active assignees, led by mRNA and RNA-therapeutics developers, mapping onto the same entities visible in the litigation; the United States leads on geography, followed by China, with a notable Canadian share reflecting the field's foundational lipid lineage. Because applications publish about eighteen months after filing, the newest lipid, targeting, and process filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The practical consequence is that delivery IP now shapes the economics of the entire RNA field. A developer typically needs freedom to operate on the ionizable lipid and the composition, plus the formulation and manufacturing process, and that can mean licensing from or designing around several holders. The durable value is concentrating in novel ionizable lipids, where iterative and structure-activity design continues to yield new, patentable chemistries,⁷ down to fine distinctions such as lipid isomerism that measurably change performance,⁸ in compositions that fall outside the contested molar-ratio claims, in targeting chemistries that reach tissues beyond the liver, and in manufacturing processes. Reading the landscape by lipid, layer, and owner, and tracking the live proceedings, is what separates a workable position from a blocked one.

What creates FTO risk in LNP delivery

Ionizable lipid claims. These cover the structures that carry and release the nucleic acid, the most heavily contested layer and the frequent center of litigation.²

Molar-ratio and composition claims. These cover the specific percentage ranges of the four lipid components, a layer that can block a formulation independently of the individual lipids.³

PEG-lipid and helper-lipid claims. These cover the stabilizing and structural lipids, a distinct and separately owned layer.

Formulation and manufacturing claims. These cover the process by which LNPs are assembled at scale, where practical, hard-to-design-around barriers concentrate.

Targeting and application claims. These cover tissue-targeting chemistries and specific cargo applications, so a delivery system can be free for one use and blocked for another.

How AI-powered landscape and FTO analysis helps

A dense, multi-owner, heavily litigated delivery landscape is beyond manual clearance. AI-powered analysis addresses this with semantic search that retrieves relevant ionizable-lipid, composition, PEG-lipid, formulation, and targeting claims regardless of terminology, attribution that resolves the many company and academic owners to canonical entities and captures the license chains, claim-level analysis that separates the layers, and continuous monitoring that tracks new filings and the live disputes. Because delivery advances appear in scientific literature before they are patented, reading both patents and literature gives earlier warning of where the field is extending.

Where Cypris fits

Cypris runs patent landscape and freedom-to-operate analysis for dense, contested fields such as LNP delivery across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters the landscape by layer, ionizable lipid, composition, PEG-lipid, formulation, and targeting, and normalizes company and academic owners to canonical entities, so a team sees how rights are distributed across the web of holders rather than a flat list. Semantic search across patents and scientific literature surfaces relevant claims regardless of terminology and connects filings to the underlying chemistry research, which is where novel lipids and targeting approaches emerge first. Cypris Q, the platform's agentic layer, lets teams run landscape and FTO analysis conversationally and chain the attribution, clustering, and claim-level analysis across layers, and Agentic Monitoring tracks the landscape over time and flags new filings and developments as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

Why is freedom-to-operate hard for lipid nanoparticles? Freedom-to-operate is hard for lipid nanoparticles because an LNP is built from four lipid components combined in specific ratios by a specific process, each independently patentable and held across many owners. The ionizable lipid and molar-ratio composition are especially contested. FTO must be assessed layer by layer across multiple estates, often for a delivery system rather than the drug itself.

Why is LNP the binding constraint for RNA products? LNP is frequently the binding constraint because delivery, not the nucleic acid payload, is the hardest part of an RNA medicine, and the delivery IP is densely held. A product can clear its therapeutic sequence and still be blocked on the lipid or the composition. That is why delivery litigation has been so consequential.

What claim types create FTO risk in LNP delivery? Five claim types create FTO risk: ionizable-lipid claims, molar-ratio and composition claims, PEG-lipid and helper-lipid claims, formulation and manufacturing claims, and targeting and application claims. Each covers a distinct layer and can independently block a product. Ionizable lipids and molar ratios are the most litigated.

Why has LNP patent litigation been so significant? LNP patent litigation has been significant because the technology enabled a very large market, and rights are held across several estates traceable to a few foundational lineages. Disputes over ionizable lipids, molar ratios, and formulation have produced high-value cases and settlements across jurisdictions, including a multi-billion-dollar 2026 settlement between Genevant and Arbutus and Moderna. Outcomes turn on the specific patents asserted rather than a single view of the technology.

Where is the white space in LNP delivery? The white space sits in novel ionizable lipids, compositions outside the contested molar-ratio claims, targeting chemistries that reach tissues beyond the liver, non-PEG stabilization, and manufacturing processes. The core lipid and composition ground is crowded and litigated. The durable, defensible value is in these newer chemistry and process layers.

Why does LNP analysis need scientific literature? LNP analysis needs scientific literature because new lipids, targeting chemistries, and formulation advances appear in research before they are patented, so the literature gives the earliest signal. Analyzing patents alone gives a lagging view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the LNP delivery patent landscape? Software for the LNP delivery landscape should resolve the many company and academic owners and license chains to canonical entities, cluster the ionizable-lipid, composition, formulation, and targeting layers, search patents and scientific literature semantically, and monitor active litigation and new filings continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams need LNP patent landscape and FTO analysis? LNP patent landscape and FTO analysis is needed by R&D, IP, and business-development teams at mRNA, RNA-therapeutic, vaccine, and gene-editing companies, as well as investors assessing RNA assets. Because delivery is often the binding constraint, structured analysis is essential. Cypris serves hundreds of enterprise customers across pharmaceuticals and other research-intensive industries.

Endnotes

1. Liu, S., Zhang, X., Zhang, Y., & Gao, Y. (2024). Principles of lipid nanoparticle design for mRNA delivery. BMEMat. https://doi.org/10.1002/bmm2.12116
2. Han, X., Tang, X., & Zhang, Y. (2023). Ionizable lipid nanoparticles for mRNA delivery. Advanced NanoBiomed Research, 3. https://doi.org/10.1002/anbr.202300006
3. Fenton, O. S., Anderson, D. G., et al. (2015). Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Letters, 15(11). https://doi.org/10.1021/acs.nanolett.5b02497
4. Genevant Sciences & Arbutus Biopharma (2026, March 3). Genevant Sciences and Arbutus Biopharma announce $2.25 billion global settlement with Moderna. https://www.genevant.com/genevant-sciences-and-arbutus-biopharma-announce-2-25-billion-global-settlement-with-moderna
5. Roivant Sciences (2026). Settlement disclosure (Exhibit 99.1), U.S. Securities and Exchange Commission. https://www.sec.gov/Archives/edgar/data/1635088/000114036126007548/ef20067067_ex99-1.htm
6. Arbutus Biopharma (2026, March 3). Form 8-K. https://investor.arbutusbio.com/static-files/f6868345-37b9-4bd3-9ba3-799e754e6ce1
7. Manning, A. M., Khan, O. F., et al. (2023). Iterative design of ionizable lipids for intramuscular mRNA delivery. Journal of the American Chemical Society, 145(4). https://doi.org/10.1021/jacs.2c10670
8. Zuo, T., He, Z., Li, Z., et al. (2026). Unraveling the role of ionizable lipid isomerism in modulating lipid nanoparticles for mRNA delivery. Journal of the American Chemical Society. https://doi.org/10.1021/jacs.5c20438

Neuromorphic computing is emerging as a distinct answer to the energy cost of artificial intelligence, and its patent landscape is unusually cross-disciplinary because a neuromorphic system is built from semiconductors, novel materials, and AI at the same time. Where conventional processors shuttle data between separate memory and compute units, an arrangement whose data movement dominates the energy budget, neuromorphic designs borrow from the brain: they compute where the data sits, in analog crossbar arrays that perform multiply-accumulate operations in place,¹,² communicate through sparse, event-driven spikes rather than continuous clocked operations, and store synaptic weights in analog or non-volatile devices.³ The intellectual property divides across several regions, each with different owners and maturity: the synaptic device materials, such as resistive, phase-change, and ferroelectric elements, that hold and update weights; the in-memory and analog compute circuits, often built as crossbar arrays, that perform computation in place; the spiking-processor architectures that route events across many cores; the event-based sensors, such as dynamic vision sensors, that feed them; and the on-chip learning rules and software stacks that make the hardware usable. Because a working system depends on all of these, freedom-to-operate and white space analysis must span the full stack.

The convergence of in-memory computing with spiking neural networks is now a well-reviewed field, spanning resistive, phase-change, ferroelectric, floating-gate, and optoelectronic synaptic devices,⁴,⁵ and it draws in several industries at once, which shapes where the IP concentrates. Large processor and memory companies, specialized neuromorphic startups, sensor makers, and academic groups are each building in different layers, so ownership is fragmented across the device, circuit, architecture, sensor, and algorithm regions rather than held by a single set of players. The patent record reflects this: across the Cypris corpus of more than 500 million patents and scientific papers, the neuromorphic, in-memory, and resistive-switching space holds on the order of 40,000 de-duplicated families and has grown steadily with a step-up in 2025, and the most active assignees are semiconductor and IT majors, including IBM, Hewlett Packard Enterprise, Samsung, and Intel, alongside strong academic filers, with China and the United States the leading jurisdictions; because assignee names are not fully canonicalized, corporate totals are best read as indicative. The commercial pull is strongest at the edge, where power and latency budgets are tight and brain-inspired efficiency has the clearest advantage. Because applications publish about eighteen months after filing, the most recent device and architecture filings are under-represented, so the current frontier is more active than granted-patent counts suggest.

The strategic question is which layer to back, and the white space sits where the physics is hardest. Analog in-memory computation promises the largest efficiency gains but must overcome device variability and precision limits, so materials and circuit techniques that make it reliable carry high, defensible value. Novel synaptic device materials, including optoelectronic elements that couple light and memory,⁷ and on-chip learning rules such as spike-timing-dependent plasticity demonstrated directly in memristor synapses,⁶ are active and comparatively open, while the software and compilation layers that connect neuromorphic hardware to mainstream AI frameworks remain underdeveloped and strategically important. Reading the landscape by layer, and tracking both the patents and the underlying device and algorithm research, is what separates a crowded region from an open one.

Where the neuromorphic white space is

Analog in-memory compute. Reliable analog computation in memory arrays promises the largest efficiency gains but must solve device variability and precision, a high-value, still-open target.¹

Novel synaptic devices. Resistive, phase-change, ferroelectric, and optoelectronic elements that store and update weights are an active materials layer with room for defensible positions.⁷

On-chip learning. Learning rules such as spike-timing-dependent plasticity that let a device adapt without a separate training system are a differentiated and comparatively open capability.⁶

Event-based sensing. Dynamic vision and other event-driven sensors that pair naturally with spiking processors are an active, less-crowded hardware layer.

Software and compilation stacks. Toolchains that map mainstream AI models onto neuromorphic hardware are underdeveloped and strategically important.

How AI-powered landscape and white space analysis helps

Resolving a landscape that spans device materials, compute circuits, processor architectures, sensors, and software requires more than keyword search. AI-powered analysis addresses this with semantic search that clusters activity by layer across varied terminology, attribution that normalizes semiconductor, startup, and academic filers to canonical entities, and continuous monitoring that keeps pace with a cross-disciplinary field. Because neuromorphic advances appear in scientific literature before they are patented, and because the field draws on materials, circuits, and AI at once, reading both patents and literature gives the earliest and fullest signal of where the frontier is moving.

Where Cypris fits

Cypris runs patent landscape and white space analysis for cross-disciplinary deep-tech fields such as neuromorphic computing across a corpus of more than 500 million patents and scientific papers, organized through a proprietary R&D ontology. The ontology clusters activity by layer, synaptic device, in-memory circuit, spiking architecture, event-based sensor, and learning and software, and normalizes semiconductor, startup, and academic filers to canonical entities, so a team can resolve which layers are crowded and which remain open as white space. Semantic search across patents and scientific literature connects filings to the underlying device and machine-learning research, which is where neuromorphic advances appear first, spanning the semiconductor, materials, and AI disciplines the field draws on. Cypris Q, the platform's agentic layer, lets teams run landscape and white space analysis conversationally and chain the clustering, attribution, and gap analysis, and Agentic Monitoring tracks a defined layer over time and flags new patents and papers as they publish. Cypris provides enterprise API partnerships with OpenAI, Anthropic, and Google, and is built with enterprise-grade security. Cypris serves hundreds of enterprise customers across pharmaceuticals, chemicals, advanced materials, energy, and other regulated industries.

FAQ

What is neuromorphic computing? Neuromorphic computing is a brain-inspired approach that processes information where it is stored, communicates through sparse event-driven spikes, and holds weights in analog or non-volatile devices, aiming to cut the energy cost of AI. It contrasts with conventional processors that separate memory and compute. Its advantage is clearest for low-power, low-latency workloads at the edge.

What layers does the neuromorphic patent landscape cover? The neuromorphic landscape covers synaptic device materials, in-memory and analog compute circuits, spiking-processor architectures, event-based sensors, and on-chip learning and software stacks. It is cross-disciplinary, drawing on semiconductors, materials, and AI. Freedom-to-operate and white space analysis must span all of these layers.

Who is active in neuromorphic computing patents? Activity spans large processor and memory companies, specialized neuromorphic startups, sensor makers, and academic groups, each building in different layers, so ownership is fragmented across the device, circuit, architecture, sensor, and algorithm regions. No single set of players holds the whole stack. That fragmentation makes structured landscape analysis valuable.

Where is the white space in neuromorphic computing? The white space includes reliable analog in-memory compute, novel synaptic device materials, on-chip learning, event-based sensing, and software and compilation stacks. Analog in-memory computation offers the largest efficiency gains but is the hardest to make reliable. The software layer that connects neuromorphic hardware to mainstream AI is underdeveloped and strategically important.

Why is in-memory compute a key IP area? In-memory compute is a key IP area because performing computation where data is stored avoids the energy cost of moving data, which is the main efficiency advantage of neuromorphic systems. Making analog in-memory computation reliable requires solving device variability and precision. The materials and circuit techniques that achieve this are foundational and defensible.

Why does neuromorphic analysis need scientific literature? Neuromorphic analysis needs scientific literature because device, circuit, and algorithm advances appear in research before they are patented, and the field's cross-disciplinary nature means relevant work spans several areas, so the literature gives the earliest and fullest signal. Analyzing patents alone gives a lagging, partial view. Cypris analyzes both across more than 500 million patents and scientific papers.

What software helps analyze the neuromorphic computing patent landscape? Software for the neuromorphic landscape should cluster activity by device, circuit, architecture, sensor, and software layer, resolve semiconductor, startup, and academic filers to canonical owners, search patents and scientific literature semantically, and monitor a cross-disciplinary field continuously. Cypris does this across more than 500 million patents and scientific papers using a proprietary R&D ontology, semantic search, Cypris Q, and Agentic Monitoring.

Which teams use neuromorphic patent landscape analysis? Neuromorphic patent landscape analysis is used by R&D, IP, and strategy teams at semiconductor, AI-hardware, and sensor companies, edge-AI developers, and their suppliers, as well as investors and research institutions. It informs which layer to back, where to file, and where competitors are concentrated. Cypris serves hundreds of enterprise customers across research-intensive and regulated industries.

Endnotes

1. Musisi-Nkambwe, M., Afshari, S., Sanchez Esqueda, I., Kozicki, M. N., & Barnaby, H. (2021). The viability of analog-based accelerators for neuromorphic computing: a survey. Neuromorphic Computing and Engineering, 1(1). https://doi.org/10.1088/2634-4386/ac0242
2. Hu, M., Rose, G. S., Chen, Y., Li, H., et al. (2014). Memristor crossbar-based neuromorphic computing system: a case study. IEEE Transactions on Neural Networks and Learning Systems, 25(10). https://doi.org/10.1109/tnnls.2013.2296777
3. Xiao, Z., Hu, Q., Chu, P. K., Zhang, X., & Huang, A. (2018). Neuromorphic computing with memristor crossbar. Physica Status Solidi (a), 215(20). https://doi.org/10.1002/pssa.201700875
4. Review of memristors for in-memory computing and spiking neural networks. (2025). Advanced Intelligent Systems. https://doi.org/10.1002/aisy.202500806
5. Basu, A., & Hasler, J. (2024). Historical perspective and opportunity for computing in memory using floating-gate and resistive non-volatile computing including neuromorphic computing. Neuromorphic Computing and Engineering, 4(4). https://doi.org/10.1088/2634-4386/ad9b4a
6. Pahlavan, S., Linares-Barranco, B., Serrano-Gotarredona, T., & Shooshtari, M. (2025). Spike-timing-dependent plasticity and synaptic consolidation in HfO2 memristors for adaptive neuromorphic computing. Neuromorphic Computing and Engineering. https://doi.org/10.1088/2634-4386/ae1da1
7. Pereira, M., Kiazadeh, A., Martins, R., Fortunato, E., & Barquinha, P. (2023). Recent progress in optoelectronic memristors for neuromorphic and in-memory computation. Neuromorphic Computing and Engineering, 3(2). https://doi.org/10.1088/2634-4386/acd4e2

‍